PD L1 News and Research

RSS
Scientists introduce a new approach for immunological tumor treatment

Scientists introduce a new approach for immunological tumor treatment

Scientists engineer natural killer cells that target tumors and their immunosuppressive allies

Scientists engineer natural killer cells that target tumors and their immunosuppressive allies

Protein profile in serum reflects COVID-19 severity

Protein profile in serum reflects COVID-19 severity

Manipulating macrophages could be a viable strategy for treating cancer

Manipulating macrophages could be a viable strategy for treating cancer

New combination of biomarkers can benefit patients with advanced bladder cancer

New combination of biomarkers can benefit patients with advanced bladder cancer

Novel immunotherapy-plus-chemotherapy combo for pleural mesothelioma shows promise

Novel immunotherapy-plus-chemotherapy combo for pleural mesothelioma shows promise

Jane and Aatos Erkko Foundation awards 1.5 million euros to support breast cancer study

Jane and Aatos Erkko Foundation awards 1.5 million euros to support breast cancer study

Novel immunotherapy targeting myeloid immune cells reduces tumor growth

Novel immunotherapy targeting myeloid immune cells reduces tumor growth

Novel biomarkers linked to improved outcomes with immunotherapy in metastatic breast cancer

Novel biomarkers linked to improved outcomes with immunotherapy in metastatic breast cancer

Durvalumab plus chemotherapy improved overall survival rate for mesothelioma patients

Durvalumab plus chemotherapy improved overall survival rate for mesothelioma patients

Roswell Park team proposes possible new strategy for treating pancreatic cancer

Roswell Park team proposes possible new strategy for treating pancreatic cancer

Innovative approach turns 'cold' tumors 'hot' to improve cancer immunotherapy

Innovative approach turns 'cold' tumors 'hot' to improve cancer immunotherapy

Patients with aggressive form of skin cancer can benefit from new type of immunotherapy

Patients with aggressive form of skin cancer can benefit from new type of immunotherapy

Combination therapy boosts the immune system's appetite for cancer

Combination therapy boosts the immune system's appetite for cancer

Researchers uncover how cancer cells don their invisibility cloaks

Researchers uncover how cancer cells don their invisibility cloaks

Tumors commandeer cell death pathway to avoid immune system attack after radiation

Tumors commandeer cell death pathway to avoid immune system attack after radiation

Study helps predict which ovarian cancer patients will not benefit from immune-PARP combo

Study helps predict which ovarian cancer patients will not benefit from immune-PARP combo

Study paves way for identifying ovarian cancer patients who will not benefit from combination therapy

Study paves way for identifying ovarian cancer patients who will not benefit from combination therapy

Levels of sBTLA proteins may be a marker of overall survival in patients with HCC

Levels of sBTLA proteins may be a marker of overall survival in patients with HCC

Breakthrough technology identifies proteins' nearest neighbors on cell surfaces

Breakthrough technology identifies proteins' nearest neighbors on cell surfaces